Erdogan-Trinkaus Ipek
All 5 shown
- Eton Pharmaceuticals, Inc. Chief commercial officer3,500 sharesOption exercise
- Eton Pharmaceuticals, Inc. Chief commercial officer$78,739Open-market sale
- Eton Pharmaceuticals, Inc. Chief commercial officer$157,198Open-market sale
- Eton Pharmaceuticals, Inc. Chief commercial officer$54,145Option exercise
- Eton Pharmaceuticals, Inc. Chief commercial officer80,000 sharesGrant